Why Moderna Stock Is Sinking Today
Portfolio Pulse from Ryan Gustafson
Moderna, Inc. (NASDAQ:MRNA) shares are trading lower alongside other vaccine stocks amid a selloff after the sector gained amid rising COVID-19 cases. The weakness comes after Pfizer announced it expects a 24% vaccination rate this year. Moderna's stock has gained nearly 10% in the past few weeks due to rising COVID cases in the US, but was down nearly 9% on Monday.
September 18, 2023 | 7:29 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Moderna's stock is trading lower amid a selloff in vaccine stocks. Despite a recent gain of nearly 10% due to rising COVID cases, the stock was down nearly 9% on Monday.
Moderna's stock is trading lower due to a selloff in the vaccine sector, which was triggered by Pfizer's announcement of a 24% expected vaccination rate this year. Despite a recent gain of nearly 10% due to rising COVID cases, Moderna's stock was down nearly 9% on Monday, indicating a negative short-term impact.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100